Invention Grant
- Patent Title: Isolation, expansion and use of clonogenic endothelial progenitor cells
-
Application No.: US14928383Application Date: 2015-10-30
-
Publication No.: US10767161B2Publication Date: 2020-09-08
- Inventor: Mervin C. Yoder , David A. Ingram
- Applicant: Indiana University Research and Technology Corporation
- Applicant Address: US IN Indianapolis
- Assignee: Indiana University Research and Technology Corporation
- Current Assignee: Indiana University Research and Technology Corporation
- Current Assignee Address: US IN Indianapolis
- Agency: Stinson LLP
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/0789 ; C12N5/071 ; G01N33/50 ; G01N33/569 ; A61K35/12

Abstract:
A hierarchy of endothelial colony forming cells (EPCs) was identified from mammalian cord blood, umbilical vein and aorta. A newly isolated cell named high proliferative potential—endothelial colony forming cell (HPP-ECFC) was isolated and characterized. Single cell assays were developed that test the proliferative and clonogenic potential of endothelial cells derived from cord blood, or from HUVECs and HAECs. EPCs were found to reside in vessel walls. Use of a feeder layer of cells derived from high proliferative potential-endothelial colony forming cells (HPP-ECPCS) from human umbilical cord blood, stimulates growth and survival of repopulating hematopoietic stem and progenitor cells. Stimulation of growth and survival was determined by increased numbers of progenitor cells in in vitro cultures and increased levels of human cell engraftment in the NOD/SCID immunodeficient mouse transplant system.
Public/Granted literature
- US20160115454A1 ISOLATION, EXPANSION AND USE OF CLONOGENIC ENDOTHELIAL PROGENITOR CELLS Public/Granted day:2016-04-28
Information query